Vikram Malhotra
Stock Analyst at Mizuho
(2.58)
# 2,188
Out of 4,711 analysts
149
Total ratings
51.85%
Success rate
0.06%
Average return
Main Sectors:
Stocks Rated by Vikram Malhotra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPW Medical Properties Trust | Maintains: Neutral | $6 → $5 | $3.86 | +29.53% | 4 | Dec 5, 2024 | |
| DOC Healthpeak Properties | Maintains: Outperform | $25 → $24 | $20.12 | +19.28% | 2 | Dec 5, 2024 | |
| SBRA Sabra Health Care REIT | Downgrades: Neutral | $20 | $16.96 | +17.92% | 3 | Dec 5, 2024 | |
| EQIX Equinix | Maintains: Outperform | $873 → $971 | $927.22 | +4.72% | 2 | Sep 12, 2024 | |
| REXR Rexford Industrial Realty | Maintains: Neutral | $50 → $49 | $38.02 | +28.88% | 4 | Sep 5, 2024 | |
| TRNO Terreno Realty | Downgrades: Underperform | $62 | $58.99 | +5.10% | 5 | Sep 5, 2024 | |
| EGP EastGroup Properties | Upgrades: Outperform | $175 → $200 | $161.44 | +23.89% | 8 | Sep 5, 2024 | |
| LINE Lineage | Initiates: Neutral | $86 | $58.57 | +46.83% | 1 | Aug 19, 2024 | |
| PLD Prologis | Maintains: Neutral | $130 → $120 | $103.32 | +16.14% | 12 | May 31, 2024 | |
| MAA Mid-America Apartment Communities | Maintains: Neutral | $126 → $130 | $153.40 | -15.25% | 5 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $194 | $222.17 | -12.68% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $24 | $27.40 | -12.41% | 3 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $154 | $99.17 | +55.29% | 6 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $4.81 | +24.74% | 8 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $40 | $40.50 | -1.23% | 5 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $24 | $30.08 | -20.21% | 10 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $22 → $19 | $30.24 | -37.17% | 5 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $68 | $74.64 | -8.90% | 6 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $7 | $2.93 | +138.91% | 10 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $55 | $50.73 | +8.42% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $38 | $68.01 | -44.13% | 9 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $25 → $23 | $41.51 | -44.59% | 11 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $65 | $58.76 | +10.62% | 5 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $96 | $124.64 | -22.98% | 5 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $25 | $13.09 | +90.99% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $35 | $38.10 | -8.14% | 1 | Feb 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $96 → $75 | $19.51 | +284.42% | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 → $28 | $31.53 | -11.20% | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $41 → $40 | $26.00 | +53.85% | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $31 → $33 | $16.88 | +95.50% | 2 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $74 | $52.79 | +40.18% | 4 | Apr 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4.75 → $5 | $2.28 | +119.30% | 3 | Mar 15, 2021 |
Medical Properties Trust
Dec 5, 2024
Maintains: Neutral
Price Target: $6 → $5
Current: $3.86
Upside: +29.53%
Healthpeak Properties
Dec 5, 2024
Maintains: Outperform
Price Target: $25 → $24
Current: $20.12
Upside: +19.28%
Sabra Health Care REIT
Dec 5, 2024
Downgrades: Neutral
Price Target: $20
Current: $16.96
Upside: +17.92%
Equinix
Sep 12, 2024
Maintains: Outperform
Price Target: $873 → $971
Current: $927.22
Upside: +4.72%
Rexford Industrial Realty
Sep 5, 2024
Maintains: Neutral
Price Target: $50 → $49
Current: $38.02
Upside: +28.88%
Terreno Realty
Sep 5, 2024
Downgrades: Underperform
Price Target: $62
Current: $58.99
Upside: +5.10%
EastGroup Properties
Sep 5, 2024
Upgrades: Outperform
Price Target: $175 → $200
Current: $161.44
Upside: +23.89%
Lineage
Aug 19, 2024
Initiates: Neutral
Price Target: $86
Current: $58.57
Upside: +46.83%
Prologis
May 31, 2024
Maintains: Neutral
Price Target: $130 → $120
Current: $103.32
Upside: +16.14%
Mid-America Apartment Communities
May 30, 2024
Maintains: Neutral
Price Target: $126 → $130
Current: $153.40
Upside: -15.25%
May 30, 2024
Maintains: Neutral
Price Target: $185 → $194
Current: $222.17
Upside: -12.68%
Feb 23, 2024
Downgrades: Neutral
Price Target: $23 → $24
Current: $27.40
Upside: -12.41%
Jan 3, 2024
Maintains: Buy
Price Target: $145 → $154
Current: $99.17
Upside: +55.29%
Oct 18, 2023
Maintains: Buy
Price Target: $7 → $6
Current: $4.81
Upside: +24.74%
Oct 18, 2023
Maintains: Buy
Price Target: $48 → $40
Current: $40.50
Upside: -1.23%
Oct 18, 2023
Maintains: Neutral
Price Target: $31 → $24
Current: $30.08
Upside: -20.21%
Oct 18, 2023
Maintains: Underperform
Price Target: $22 → $19
Current: $30.24
Upside: -37.17%
Oct 18, 2023
Maintains: Buy
Price Target: $85 → $68
Current: $74.64
Upside: -8.90%
Oct 18, 2023
Upgrades: Neutral
Price Target: $7
Current: $2.93
Upside: +138.91%
Jun 12, 2023
Reiterates: Neutral
Price Target: $55
Current: $50.73
Upside: +8.42%
Jan 4, 2023
Maintains: Neutral
Price Target: $48 → $38
Current: $68.01
Upside: -44.13%
Jan 4, 2023
Upgrades: Neutral
Price Target: $25 → $23
Current: $41.51
Upside: -44.59%
Mar 21, 2022
Maintains: Buy
Price Target: $61 → $65
Current: $58.76
Upside: +10.62%
Mar 21, 2022
Maintains: Buy
Price Target: $94 → $96
Current: $124.64
Upside: -22.98%
Mar 3, 2022
Maintains: Overweight
Price Target: $24 → $25
Current: $13.09
Upside: +90.99%
Feb 15, 2022
Maintains: Buy
Price Target: $34 → $35
Current: $38.10
Upside: -8.14%
Jan 20, 2022
Downgrades: Neutral
Price Target: $96 → $75
Current: $19.51
Upside: +284.42%
Jan 20, 2022
Downgrades: Neutral
Price Target: $35 → $28
Current: $31.53
Upside: -11.20%
Jan 20, 2022
Downgrades: Neutral
Price Target: $41 → $40
Current: $26.00
Upside: +53.85%
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $31 → $33
Current: $16.88
Upside: +95.50%
Apr 15, 2021
Maintains: Overweight
Price Target: $67 → $74
Current: $52.79
Upside: +40.18%
Mar 15, 2021
Maintains: Equal-Weight
Price Target: $4.75 → $5
Current: $2.28
Upside: +119.30%